Next |
home / stock / supn / supn message board
Subject | By | Source | When |
---|---|---|---|
Just found this one - Well over a | ncstrongman | investorshub | 04/11/2022 12:49:30 PM |
I hope everyone got some 28 es because | ball8281 | investorshub | 12/23/2020 1:24:09 AM |
Wow thats amazing news tomorrow gap up will | ball8281 | investorshub | 12/23/2020 1:23:21 AM |
Boom were heading to 50 dollars a share tomorrow | ball8281 | investorshub | 12/23/2020 1:22:53 AM |
what about the PDUFA on the 8th? will | Diwanssong | investorshub | 11/06/2020 4:54:47 PM |
znewcar1: SUPN 23% v2,0M c22.47 f52,6M preMH23 H22.87 gap dip to 20.2 then sideways | znewcar1 | investorshangout | 11/05/2020 12:00:04 AM |
NEWS: $SUPN Supernus Pharmaceuticals Inc ($SUPN) Q3 2020 | whytestocks | investorshub | 11/04/2020 6:45:23 PM |
$SUPN will easily be over 50 dollars on | dinogreeves | investorshub | 11/04/2020 2:55:41 PM |
30-35 dollars easy tomorrow with this awesome earnings | dinogreeves | investorshub | 11/03/2020 11:36:48 PM |
* * $SUPN Video Chart 11-06-19 * * | ClayTrader | investorshub | 11/06/2019 10:28:36 PM |
znewcar1: 14% 2.6M C57.05 hod 57.95 Great vol multi day runner | znewcar1 | investorshangout | 05/11/2018 8:43:00 PM |
$SUPN on watch for bottom to drop out | ClarkKant | investorshub | 09/19/2017 2:43:57 PM |
https://stocknews.com/news/supn-cantor-fitzgerald-reiterates-overweight-rating-3 | joegrantjr | investorshub | 04/07/2017 6:04:25 PM |
$SUPN continues to be a big winner. Just | cars100cars | investorshub | 04/07/2017 12:46:19 PM |
Big news AH. Go $SUPN | Chuck87 | investorshub | 04/06/2017 12:38:29 AM |
Great Conference Call and Another Big Growth Year | cars100cars | investorshub | 03/10/2017 7:16:46 PM |
Positive SA article on $SUPN: | H2R | investorshub | 01/05/2017 9:58:57 PM |
riddock57: Supernus Pharmaceuticals (Nasdaq:SUPN) Wins Patent Battle With Actavis | riddock57 | investorshangout | 12/13/2016 8:06:59 AM |
No reason for $SUPN to sell off. FDA | cars100cars | investorshub | 11/04/2016 4:06:17 PM |
Supernus Announces Positive Results from Phase IIb Clinical | crudeoil24 | investorshub | 10/11/2016 12:51:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Supernus Pharmaceuticals Inc. Company Name:
SUPN Stock Symbol:
NASDAQ Market:
Supernus Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing...
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company will hold a webcast and confe...
Net sales of Qelbree ® increased 75% to $45.1 million compared to first quarter 2023. Total revenues were $143.6 million. Total revenues excluding Trokendi XR ® and Oxtellar XR ® net product sales (non-GAAP) (1) increased 12% to $100.7 million compared to first ...